In Vitro Pharmacology of Mitragynine at α-Adrenoceptors. [PDF]
Chen Y +10 more
europepmc +1 more source
Avoiding False Identification of 7-Hydroxymitragynine in Kratom Products Using a Multicriteria LC-MS Confirmation. [PDF]
Sheehan D +4 more
europepmc +1 more source
Severe Early-Onset Withdrawal Following Intentional Use of Mitragynine Pseudoindoxyl: A Case Report and Emerging Clinical Considerations. [PDF]
Stanciu CN.
europepmc +1 more source
Kratom Cutaneous Hyperpigmentation: An Emerging Dermatosis for Dermatopathologists and Dermatologists to Recognize. [PDF]
Pei S, Fung MA, Piliang M, Rubin AI.
europepmc +1 more source
From kratom to 7-hydroxymitragynine: evolution of a natural remedy into a public-health threat. [PDF]
Alsbrook S, Pro G, Koturbash I.
europepmc +1 more source
Evaluation of the unregulated online kratom market in two east-central European countries: test purchase and analysis of potential toxicological consequences. [PDF]
Balázs O +12 more
europepmc +1 more source
Abuse potential and adverse cognitive effects of mitragynine (kratom)
Mitragynine is the major psychoactive alkaloid of the plant kratom/ketum. Kratom is widely used in Southeast Asia as a recreational drug, and increasingly appears as a pure compound or a component of ‘herbal high’ preparations in the Western world. While
Farah Wahida Suhaimi +2 more
exaly +2 more sources

